The Manufacturers Life Insurance Company boosted its holdings in shares of Transcat, Inc. (NASDAQ:TRNS – Free Report) by 8.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,312 shares of the scientific and technical instruments company’s stock after acquiring an additional 263 shares during the period. The Manufacturers Life Insurance Company’s holdings in Transcat were worth $396,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in TRNS. DekaBank Deutsche Girozentrale bought a new position in Transcat during the second quarter worth about $40,000. First Horizon Advisors Inc. lifted its holdings in Transcat by 26.4% during the second quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after acquiring an additional 125 shares in the last quarter. Fifth Third Bancorp lifted its holdings in Transcat by 95.8% during the second quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company’s stock worth $79,000 after acquiring an additional 321 shares in the last quarter. Quest Partners LLC bought a new position in Transcat during the second quarter worth about $109,000. Finally, Hamilton Wealth LLC acquired a new stake in shares of Transcat in the 1st quarter valued at about $212,000. 98.34% of the stock is currently owned by institutional investors.
Transcat Stock Performance
NASDAQ:TRNS opened at $128.80 on Thursday. The stock’s 50-day simple moving average is $122.50 and its 200 day simple moving average is $121.36. The company has a market cap of $1.18 billion, a P/E ratio of 76.21 and a beta of 0.67. Transcat, Inc. has a 52-week low of $84.45 and a 52-week high of $147.12.
Wall Street Analyst Weigh In
TRNS has been the topic of several recent research reports. HC Wainwright reissued a “buy” rating and issued a $156.00 price target on shares of Transcat in a research note on Tuesday, July 30th. Craig Hallum dropped their price target on Transcat from $150.00 to $138.00 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Transcat presently has an average rating of “Moderate Buy” and a consensus target price of $151.33.
Read Our Latest Research Report on TRNS
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Read More
- Five stocks we like better than Transcat
- About the Markup Calculator
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Plot Fibonacci Price Inflection Levels
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Do ETFs Pay Dividends? What You Need to Know
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.